1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Assays & kits
1.2.3 Instruments & Analyzers
1.2.4 Software & Services
1.3 Market by Application
1.3.1 Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Physicians’ Offices
1.3.3 Hospitals & ICUs
1.3.4 Research Institutes
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Molecular Diagnostic Solution Market Perspective (2017-2028)
2.2 Point-of-care Molecular Diagnostic Solution Growth Trends by Region
2.2.1 Point-of-care Molecular Diagnostic Solution Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Point-of-care Molecular Diagnostic Solution Historic Market Size by Region (2017-2022)
2.2.3 Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Region (2023-2028)
2.3 Point-of-care Molecular Diagnostic Solution Market Dynamics
2.3.1 Point-of-care Molecular Diagnostic Solution Industry Trends
2.3.2 Point-of-care Molecular Diagnostic Solution Market Drivers
2.3.3 Point-of-care Molecular Diagnostic Solution Market Challenges
2.3.4 Point-of-care Molecular Diagnostic Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Molecular Diagnostic Solution Players by Revenue
3.1.1 Global Top Point-of-care Molecular Diagnostic Solution Players by Revenue (2017-2022)
3.1.2 Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Players (2017-2022)
3.2 Global Point-of-care Molecular Diagnostic Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-care Molecular Diagnostic Solution Revenue
3.4 Global Point-of-care Molecular Diagnostic Solution Market Concentration Ratio
3.4.1 Global Point-of-care Molecular Diagnostic Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Molecular Diagnostic Solution Revenue in 2021
3.5 Point-of-care Molecular Diagnostic Solution Key Players Head office and Area Served
3.6 Key Players Point-of-care Molecular Diagnostic Solution Product Solution and Service
3.7 Date of Enter into Point-of-care Molecular Diagnostic Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Molecular Diagnostic Solution Breakdown Data by Type
4.1 Global Point-of-care Molecular Diagnostic Solution Historic Market Size by Type (2017-2022)
4.2 Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Type (2023-2028)
5 Point-of-care Molecular Diagnostic Solution Breakdown Data by Application
5.1 Global Point-of-care Molecular Diagnostic Solution Historic Market Size by Application (2017-2022)
5.2 Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
6.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Type
6.2.1 North America Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
6.2.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
6.2.3 North America Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
6.3 North America Point-of-care Molecular Diagnostic Solution Market Size by Application
6.3.1 North America Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
6.3.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
6.3.3 North America Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
6.4 North America Point-of-care Molecular Diagnostic Solution Market Size by Country
6.4.1 North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
6.4.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
7.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Type
7.2.1 Europe Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
7.2.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
7.2.3 Europe Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
7.3 Europe Point-of-care Molecular Diagnostic Solution Market Size by Application
7.3.1 Europe Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
7.3.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
7.3.3 Europe Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
7.4 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country
7.4.1 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
7.4.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
8.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type
8.2.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
8.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application
8.3.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
8.4 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region
8.4.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
9.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type
9.2.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
9.2.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
9.2.3 Latin America Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
9.3 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application
9.3.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
9.3.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
9.3.3 Latin America Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
9.4 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country
9.4.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
9.4.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
10.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Type
10.2.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
10.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Application
10.3.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
10.4 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country
10.4.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Introduction
11.1.4 Abbott Laboratories Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 F. Hoffmann-La Roche AG
11.2.1 F. Hoffmann-La Roche AG Company Details
11.2.2 F. Hoffmann-La Roche AG Business Overview
11.2.3 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Introduction
11.2.4 F. Hoffmann-La Roche AG Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.2.5 F. Hoffmann-La Roche AG Recent Developments
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Details
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Introduction
11.3.4 Becton, Dickinson and Company Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.3.5 Becton, Dickinson and Company Recent Developments
11.4 BioMerieux
11.4.1 BioMerieux Company Details
11.4.2 BioMerieux Business Overview
11.4.3 BioMerieux Point-of-care Molecular Diagnostic Solution Introduction
11.4.4 BioMerieux Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.4.5 BioMerieux Recent Developments
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Details
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.5.5 Bio-Rad Laboratories, Inc. Recent Developments
11.6 Cepheid, Inc.
11.6.1 Cepheid, Inc. Company Details
11.6.2 Cepheid, Inc. Business Overview
11.6.3 Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Introduction
11.6.4 Cepheid, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.6.5 Cepheid, Inc. Recent Developments
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Details
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Point-of-care Molecular Diagnostic Solution Introduction
11.7.4 Danaher Corporation Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.7.5 Danaher Corporation Recent Developments
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Introduction
11.8.4 Johnson and Johnson Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.8.5 Johnson and Johnson Recent Developments
11.9 Bayer Healthcare
11.9.1 Bayer Healthcare Company Details
11.9.2 Bayer Healthcare Business Overview
11.9.3 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Introduction
11.9.4 Bayer Healthcare Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.9.5 Bayer Healthcare Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer